1. Pink Sheet
  2. >>Geography

Japan Finally Approves Mifepristone To Public Support

Use, Monitoring Requirements

 
• By Lisa Takagi

Japan has approved abortion drug mifepristone but will limit its use to clinics with authorized physicians, with strict nationwide monitoring of sales. The majority of more than 10,000 public comments around the approval were in support of the new option for women. 

Mifepristone was approved in Japan on 28 April, 2023
Japan demand for mifespristone had been rising as a new option for abortion • Source: Shutterstock

Japan has finally approved mifepristone as a new option for medical abortion, amid rising demand from the public for the oral drug and a desire to properly regulate its use.

While a legal battle in the US over access to the drug continues, there was a contrasting direction in the regulatory decision in Japan, where Linepharma will launch it as Mefigo Pack, a combination of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Asia